ScienBio Technology Obtains Patent for Manufacturing Method of Cross-linked Hyaluronic Acid Gel Containing Special Corticosteroid

1. Date of event: 115/04/15 2. Company Name: ScienBio Technology Co., Ltd. 3. Relationship with parent company: Parent Company 4. Shareholding ratio: Not applicable 5. Reason for event: The company's patent application 'Manufacturing Method for Cross-linked Hyaluronic Acid Gel Containing Special Corticosteroid and Cross-linked Hyaluronic Acid Gel,' filed with Taiwan's Intellectual Property Office (TIPO), has been reviewed and approved, and a patent grant notice has been received. Invention Patent Application No: 113132817. 6. Measures taken: Announcement of this disclosure. 7. Other matters to be disclosed (If the subject of the event or resolution is a publicly issuing company or above, this material information also meets the requirements of Article 7, Paragraph 9 of the Securities Transaction Act Enforcement Rules for matters that have a significant impact on shareholder equity or security prices): Can be used for new product development or improvement of product efficacy, increasing product diversity, and enhancing company competitiveness. Keywords: Material Information